PredicineRNA™
Use
PredicineRNA™ is an advanced 88-gene cfRNA assay designed to detect gene fusions and splicing variants at the RNA level. The assay captures known and novel fusion genes and splicing events that are not detectable through DNA analysis alone. By analyzing RNA, the test confirms and extends DNA-based variant detection, providing a comprehensive assessment of cancer biology. This makes it a valuable tool in research settings to understand the genomic alterations in various cancers.
Special Instructions
Not provided.
Limitations
The PredicineRNA™ test is intended for research use only and is not to be utilized for diagnostic procedures. As with any liquid biopsy test, the performance may be limited by the quality and quantity of cfRNA extracted from the sample. Being an RNA-focused test, it cannot capture DNA-only alterations such as certain copy number changes.
Methodology
NGS (Targeted)
Biomarkers
TMPRSS2, ERG
GeneNo genes
Gene
Result Turnaround Time
14 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
2-5 mL
Minimum Volume
Not provided